Open AccessBilateral Orchidectomy Revisited in Management of Metastatic Hormone-Sensitive Prostate Cancer
Author(s) -
Ankur Agarwala,
Somendra Bansal,
Narmada P. Gupta
Publication year - 2021
Publication title -
indian journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 16
eISSN - 0976-6952
pISSN - 0975-7651
DOI - 10.1007/s13193-021-01390-w
Subject(s) - medicine , castration , prostate cancer , urology , orchiectomy , androgen deprivation therapy , testosterone (patch) , hormone , cancer
Androgen deprivation therapy (ADT) is a well-established treatment for metastatic hormone-sensitive prostate cancer (mHSPC). It includes either bilateral orchiectomy or medical castration in form of luteinizing hormone-releasing hormone (LHRH) agonist or antagonist. We conducted this study to compare surgical and medical castration in terms of time to progression (TTP) to castration resistant prostate cancer.